URGN
Conviction 86HealthcareScan · Thu, Sep 24, 2026UroGen Pharma Ltd. (URGN) closed at $41.22 (-0.98%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and above its 200-day moving average. RSI(14) 40, RS Rating 97, -18.0% from its 52-week high, +81.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in URGN
Insider activity
SEC Form 4 transactions in URGN · open-market 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Smith Jason Drew General Counsel · Ordinary Shares · 2026-09-08 | Sell | 1.52K | $65K | 2026-09-08 | 2026-09-09 |
Schoenberg Mark Chief Medical Officer · Ordinary Shares · 2026-09-08 | Sell | 871 | $37K | 2026-09-08 | 2026-09-09 |
Smith Jason Drew General Counsel · Ordinary Shares · 2026-09-07 | Exercise | 3.33K | — | 2026-09-07 | 2026-09-09 |
Smith Jason Drew General Counsel · Restricted Stock Units · 2026-09-07 | Exercise | 3.33K | — | 2026-09-07 | 2026-09-09 |
Schoenberg Mark Chief Medical Officer · Ordinary Shares · 2026-09-07 | Exercise | 1.67K | — | 2026-09-07 | 2026-09-09 |
Schoenberg Mark Chief Medical Officer · Restricted Stock Units · 2026-09-07 | Exercise | 1.67K | — | 2026-09-07 | 2026-09-09 |
Robinson James A. Jr. Director · ordinary shares · 2026-08-26 | Exercise | 2K | — | 2026-08-26 | 2026-08-28 |
Robinson James A. Jr. Director · Restricted Stock Unit · 2026-08-26 | Exercise | 2K | — | 2026-08-26 | 2026-08-28 |
Schoenberg Mark Chief Medical Officer · ordinary shares · 2026-08-20 | Sell | 60.68K | $2.9M | 2026-08-20 | 2026-08-24 |
Schoenberg Mark Chief Medical Officer · Ordinary Shares · 2026-07-09 | Sell | 10K | $400K | 2026-07-09 | 2026-07-10 |
SEC filings
EDGAR filings in URGN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.